1. Home
  2. UFG vs ALLR Comparison

UFG vs ALLR Comparison

Compare UFG & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Uni-Fuels Holdings Limited

UFG

Uni-Fuels Holdings Limited

HOLD

Current Price

$0.82

Market Cap

29.7M

Sector

Energy

ML Signal

HOLD

Logo Allarity Therapeutics Inc.

ALLR

Allarity Therapeutics Inc.

HOLD

Current Price

$1.43

Market Cap

25.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UFG
ALLR
Founded
2021
2004
Country
Singapore
United States
Employees
17
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.7M
25.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
UFG
ALLR
Price
$0.82
$1.43
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.75
AVG Volume (30 Days)
224.8K
227.3K
Earning Date
04-22-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$320,000.00
Revenue This Year
$3.95
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$211.08
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.60
$0.77
52 Week High
$9.91
$2.35

Technical Indicators

Market Signals
Indicator
UFG
ALLR
Relative Strength Index (RSI) 49.68 45.55
Support Level $0.63 $1.29
Resistance Level $0.85 $1.80
Average True Range (ATR) 0.08 0.14
MACD 0.01 -0.04
Stochastic Oscillator 33.72 31.91

Price Performance

Historical Comparison
UFG
ALLR

About UFG Uni-Fuels Holdings Limited

Uni-Fuels Holdings Ltd is a service provider of marine fuels solutions. The company market, resell and brokers marine fuels products such as VLSFO, HSFO, and MGO. It offers these products to shipping companies and marine fuels suppliers in-port and offshore. In addition, the company may from time to time provide shipping-related services to its customers including but not limited to the arrangement of ship agents, ship provisions and marine fuels surveyors. It operates an integrated business model where It serves its customers through two operating models, sales of marine fuels solutions and brokerage.

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States. It is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP companion diagnostic.

Share on Social Networks: